Chronic obstructive pulmonary disease - mepolizumab - initial or recommencement after a 12-month break authority application form (PB403)

Use this form to apply for initial PBS-subsidised treatment with mepolizumab for uncontrolled chronic obstructive pulmonary disease (COPD).

Page last updated: 1 September 2026.
QC 84492